PHARMACEUTICAL COMPOSITION CONTAINING HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY

To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical compo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TANIMOTO MASAHIKO, MORI NAOKI, SAITO HIROSHI, IKEMOTO KEISUKE
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody suitable for administration to a subject.SOLUTION: The present invention provides a pharmaceutical composition containing a human anti-IL-33 monoclonal antibody as an active ingredient, the pharmaceutical composition containing essentially no sodium chloride or less than 30 mM sodium chloride. The present invention also provides a freeze-drying agent of the pharmaceutical composition.SELECTED DRAWING: Figure 2 【課題】本発明の目的は、対象への投与に適した、ヒト抗ＩＬ－３３モノクローナル抗体を含有する医薬用組成物を提供することである。【解決手段】本発明は、ヒト抗ＩＬ－３３モノクローナル抗体を有効成分として含有する医薬用組成物であって、塩化ナトリウムを本質的に含有しない、または、３０ｍＭ未満の塩化ナトリウムを含有する、医薬用組成物を提供する。また、本発明は、前記医薬用組成物の凍結乾燥剤を提供する。【選択図】図２